SurModics is a provider of surface modification and drug delivery solutions for the health care industry. One of SurModics core technology platforms is its patented drug delivery polymer matrix technology, which can be applied to medical devices to deliver pharmaceutical agents from the surface of a device to a targeted area of the body. For example, SurModics' Bravo drug delivery polymer matrix is used in the first-to-market drug eluting coronary stent and is being used in the I-vation Intravitreal implant. Another core surface modification technology platform is its patented PhotoLink process, which helps modify and enhance the surface characteristics of medical devices and biomedical applications improving performance and, in some cases, enabling the development of new products. The company also produces stabilization products used by manufacturers of immunoassay diagnostic tests to improve performance, stability and shelf life. SurModics is headquartered in Eden Prairie, Minn.

Evonik Corp

Biofx Laboratories Inc